NCLH vs TMO · P/E 16, rev $4.97B vs P/E 24, rev $23.00B
Norwegian Cruise Line Holdings Ltd (NCLH) versus Thermo Fisher Scientific Inc (TMO) — a side-by-side from cached financials, not a winner call.
Norwegian Cruise Line Holdings Ltd (NCLH) is a travel services company listed on NYSE.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
Latest reported NCLH revenue for 2026-06-30 was $4.97B. Net income was $327.2M. NCLH currently screens at market cap $9.10B and trailing P/E 16.0.
Latest reported TMO revenue for 2026-06-27 was $23.00B. Net income was $3.39B. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
NCLH currently screens at market cap $9.10B and trailing P/E 16.0. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Not investment advice. Open the NCLH and TMO stock pages for the full models.
Not investment advice.